Korean drugmakers urged to strengthen GMP related documentation and design

Published: 2009-09-25 06:59:00

Updated: 2009-09-25 06:59:00

Domestic pharmaceutical firms will need to fully prepare for the complete documentation, facility and machinery designs when they receive GMP related inspection from the European Medicine Agency (EMEA), according to an official at the Korea Food and Drug Administration.

In a recent seminar, the KFDA official Sung Jong-ho said that the EMEA has focused on facility and process validation durin...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.